Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 15, 2025, declared Select Dividend of Rs. 2.60 per equity share.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Amrutanjan Health Care's board approved audited results for Q4 and FY25 (ended March 31, 2025). Full-year revenue from operations rose to Rs. 45,181.63 lakhs (from Rs. 42,123.05 lakhs, up ~7.3%), while profit after tax grew to Rs. 5,083.47 lakhs (from Rs. 4,497.26 lakhs, up ~13%), with EPS at Rs. 17.58 vs Rs. 15.50. The board recommended a final dividend of Rs. 2.60 per share, taking total FY25 dividend to Rs. 3.60 per share (including Rs. 1 interim already paid), subject to AGM approval. Operating cash flow more than doubled to Rs. 5,089.92 lakhs from Rs. 2,791.06 lakhs. Statutory auditor BSR & Co. LLP issued an unmodified (clean) opinion. Additionally, Company Secretary M Srinivasan will retire on May 31, 2025, and Gagan Preet Singh will take over from June 1, 2025.
Steady single-digit revenue growth and double-digit profit growth, a clean audit opinion, and consistent dividends are mildly positive for shareholders. The leadership change at the Company Secretary level is routine and unlikely to affect operations.